Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- DAIICHI SANKYO CO LTD
- Publication Date
- 2005-05-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to compounds which can be used to treat impaired glucose tolerance to prevent or delay the onset of non-insulin dependent diabetes mellitus (NIDDM). More specifically, the present invention relates in one embodiment to the administration to a patient of certain known thiazolidinedione derivatives and related antihyperglycemic agents which reduce fasting insulin concentrations and restore normal glucose tolerance in humans , thereby preventing or delaying the onset of NI DDM or the complications caused by it. Background technique
[0002] Diabetes is one of the most prevalent chronic diseases worldwide, with considerable personal and financial burdens on patients, their families and society. There are different types of diabetes with different etiologies and pathogens. For example, diabetes is a disorder of carbohydrate metabolism characterized by hyperglycemia and glucosuria, resulting from insuffic...